Adaptative Cardiac Resynchronization Therapy in Heart Failure With Reduced EF

Escrito por: Remo H. M. Furtado em 27 de outubro de 2023

4 min de leitura

The AdaptResponse study was a randomized, multicenter, single-blind clinical trial evaluating adaptive cardiac resynchronization therapy (CRT) versus conventional CRT in patients with heart failure with reduced ejection fraction (HFrEF) and left bundle branch block (LBBB).

Quer continuar lendo?

Cadastre-se

Referência

Wilkoff BL, Filippatos G, Leclercq C, Gold MR, Hersi AS, Kusano K, Mullens W, Felker GM, Kantipudi C, El-Chami MF, Essebag V, Pierre B, Philippon F, Perez-Gil F, Chung ES, Sotomonte J, Tung S, Singh B, Bozorgnia B, Goel S, Ebert HH, Varma N, Quan KJ, Salerno F, Gerritse B, van Wel J, Schaber DE, Fagan DH, Birnie D; AdaptResponse investigators. Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial. Lancet. 2023 Sep 30;402(10408):1147-1157.

Sobre o autor

Remo H. M. Furtado

Diretor de Pesquisa do BCRI, Coordenador da Pós-graduação em Pesquisa Clínica da Galen Academy e Professor Colaborador da Faculdade de Medicina da USP